Roadside Drug Testing Devices Market (Substance: Drugs [Tetrahydrocannabinol (THC), Cocaine, Amphetamine, and Others] and Alcohol; Sample: Saliva, Breath, Urine, and Others; Modality: Handheld and Standalone) - U.S. Industry Analysis, Size, Share, Growth,

Roadside Drug Testing Devices Market (Substance: Drugs [Tetrahydrocannabinol (THC), Cocaine, Amphetamine, and Others] and Alcohol; Sample: Saliva, Breath, Urine, and Others; Modality: Handheld and Standalone) - U.S. Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Companies Mentioned

Abbott
Quest Products, LLC
CareHealth America Corporation
Oranoxis, Inc.
Drägerwerk AG & Co. KGaA
BACtrack
Lifeloc Technologies, Inc.

Countries

U.S

Forecast Year (first) - 2022

Forecast Year (last) - 2031

Forecast Year ( first)  Value - 298.9

Forecast Year (last) Value - 498.8

CAGR % - 0.053

Currency - US$ Mn


1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: U.S. Roadside Drug Testing Devices Market
4. Market Overview
4.1. Introduction
4.1.1. Substance Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. U.S. Roadside Drug Testing Devices Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Roadside Drug Testing Programs: Overview
5.2. Regulatory Scenario
5.3. Key Industry Events (mergers, acquisitions, partnerships, etc.)
5.4. COVID-19 Pandemics Impact on Industry (value chain and short / mid / long term impact)
6. U.S. Roadside Drug Testing Devices Market Analysis and Forecast, by Substance
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Substance, 2017–2031
6.3.1. Drugs
6.3.1.1. Tetrahydrocannabinol (THC)
6.3.1.2. Cocaine
6.3.1.3. Amphetamine
6.3.1.4. Others
6.3.2. Alcohol
6.4. Market Attractiveness Analysis, by Substance
7. U.S. Roadside Drug Testing Devices Market Analysis and Forecast, by Sample
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Sample, 2017–2031
7.3.1. Saliva
7.3.2. Breath
7.3.3. Urine
7.3.4. Others
7.4. Market Attractiveness Analysis, by Sample
8. U.S. Roadside Drug Testing Devices Market Analysis and Forecast, by Modality
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Modality, 2017–2031
8.3.1. Handheld
8.3.2. Standalone
8.4. Market Attractiveness Analysis, by Modality
9. Competition Landscape
9.1. Market Player - Competition Matrix (by tier and size of companies)
9.2. Market Share Analysis, by Company, 2021
9.3. Company Profiles
9.3.1. Abbott
9.3.1.1. Company overview
9.3.1.2. Financial overview
9.3.1.3. Business strategies
9.3.1.4. SWOT analysis
9.3.1.5. Recent developments
9.3.2. Quest Products, LLC
9.3.2.1. Company overview
9.3.2.2. Financial overview
9.3.2.3. Business strategies
9.3.2.4. SWOT analysis
9.3.2.5. Recent developments
9.3.3. CareHealth America Corporation
9.3.3.1. Company overview
9.3.3.2. Financial overview
9.3.3.3. Business strategies
9.3.3.4. SWOT analysis
9.3.3.5. Recent developments
9.3.4. Oranoxis, Inc.
9.3.4.1. Company overview
9.3.4.2. Financial overview
9.3.4.3. Business strategies
9.3.4.4. SWOT analysis
9.3.4.5. Recent developments
9.3.5. Drägerwerk AG & Co. KGaA
9.3.5.1. Company overview
9.3.5.2. Financial overview
9.3.5.3. Business strategies
9.3.5.4. SWOT analysis
9.3.5.5. Recent developments
9.3.6. BACtrack
9.3.6.1. Company overview
9.3.6.2. Financial overview
9.3.6.3. Business strategies
9.3.6.4. SWOT analysis
9.3.6.5. Recent developments
9.3.7. Lifeloc Technologies, Inc.
9.3.7.1. Company overview
9.3.7.2. Financial overview
9.3.7.3. Business strategies
9.3.7.4. SWOT analysis
9.3.7.5. Recent developments

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings